Munoz M. Aprepitant, When Used with Chemotherapy, Reduces the Risk of Recurrence, Metastasis, And Mortality in Patients with Breast Cancer: Aprepitant in Breast Cancer Outcomes. PJHS-Lahore [Internet]. 2026 Aug. 31 [cited 2026 Sep. 1];7(8):01-2. Available from: https://thejas.com.pk/index.php/pjhs/article/view/4537